INNOVUS PHARMA INC (INNV)

0.16
0.01 3.02
OTC
Prev Close 0.17
Open 0.17
Day Low/High 0.16 / 0.17
52 Wk Low/High 0.08 / 0.39
Volume 265.89K
Exchange OTC
Shares Outstanding 164.43B
Market Cap 27.62M
Div & Yield N.A. (N.A)

Latest News

Innovus Pharma's Apeaz™ Drug For Arthritis Pain Relief Approved For Commercialization In Canada As A Natural Health Product

Innovus Pharma's Apeaz™ Drug For Arthritis Pain Relief Approved For Commercialization In Canada As A Natural Health Product

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and...

Innovus Pharmaceuticals, Inc. Issues Statement Regarding Recent Market Activity Concerning Its Common Stock

Innovus Pharmaceuticals, Inc. Issues Statement Regarding Recent Market Activity Concerning Its Common Stock

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and...

Innovus Pharma Signs Exclusive License And Distribution Agreement With Lavasta Pharma For ProstaGorx® In Certain Middle Eastern And North African Countries

Innovus Pharma Signs Exclusive License And Distribution Agreement With Lavasta Pharma For ProstaGorx® In Certain Middle Eastern And North African Countries

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization,...

Innovus Pharma Announces Official Launch Of Its Amazon®, Walmart®, EBay® And Wish® On-Line Stores With A Combined 116 Product SKUs

Innovus Pharma Announces Official Launch Of Its Amazon®, Walmart®, EBay® And Wish® On-Line Stores With A Combined 116 Product SKUs

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization,...

Innovus Pharma Hemorrhoid Drug Xyralid™ Receives Approval In Canada

Innovus Pharma Hemorrhoid Drug Xyralid™ Receives Approval In Canada

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and...

Innovus Pharma Announces U.S. Food And Drug Administration Clearance Of Its UriVarx® Urinary Tract Infection Test Strips

Innovus Pharma Announces U.S. Food And Drug Administration Clearance Of Its UriVarx® Urinary Tract Infection Test Strips

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and...

Innovus Pharma Enters Into License And Distribution Agreement With Acerus Pharmaceuticals For The Commercialization Of UriVarx® In Canada

Innovus Pharma Enters Into License And Distribution Agreement With Acerus Pharmaceuticals For The Commercialization Of UriVarx® In Canada

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization,...

Two Innovus Pharma Products Officially Listed In OTC Section Of The RED BOOK™

Two Innovus Pharma Products Officially Listed In OTC Section Of The RED BOOK™

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization,...

Innovus Pharma Files Application For The Commercialization Of ProstaGorx® For Benign Prostatic Hyperplasia ("BPH") As A Natural Health Product In Canada

Innovus Pharma Files Application For The Commercialization Of ProstaGorx® For Benign Prostatic Hyperplasia ("BPH") As A Natural Health Product In Canada

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization,...

Innovus Pharma Expands International Distribution By Signing An Exclusive Agreement In Peru With Pharma Solutions For Zestra®, Zestra Glide®, EjectDelay® And Sensum+®

Innovus Pharma Expands International Distribution By Signing An Exclusive Agreement In Peru With Pharma Solutions For Zestra®, Zestra Glide®, EjectDelay® And Sensum+®

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization,...

Innovus Pharma's Partner Bio Task Receives Approval For Zestra® As A Cosmetic From The National Pharmaceutical Regulatory Agency, Ministry Of Health, Malaysia For Arousal And Desire

Innovus Pharma's Partner Bio Task Receives Approval For Zestra® As A Cosmetic From The National Pharmaceutical Regulatory Agency, Ministry Of Health, Malaysia For Arousal And Desire

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization,...

Innovus Pharmaceuticals Sponsors 10th Annual LD Micro Investor Conference To Be Held On December 5, 2017

Innovus Pharmaceuticals Sponsors 10th Annual LD Micro Investor Conference To Be Held On December 5, 2017

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization,...

Innovus Pharmaceuticals Strengthens Its Intellectual Property Portfolio With New Patent For Its Sensum+® Product In Mexico

Innovus Pharmaceuticals Strengthens Its Intellectual Property Portfolio With New Patent For Its Sensum+® Product In Mexico

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization,...

Innovus Pharmaceuticals Reports Nine Month Net Revenue Of $6.4 Million And Net Loss Decrease Of 51.6% Compared To The Same Period In 2016

Innovus Pharmaceuticals Reports Nine Month Net Revenue Of $6.4 Million And Net Loss Decrease Of 51.6% Compared To The Same Period In 2016

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB: INNV) today announced third quarter 2017 net revenue of $2.

Innovus Pharma Launches FlutiCare™ OTC Nasal Spray Allergy Relief In The U.S.

Innovus Pharma Launches FlutiCare™ OTC Nasal Spray Allergy Relief In The U.S.

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter ("OTC")...

Innovus Pharma Enters The $11 Billion Glucose Monitoring Market With FDA-Cleared Products Via An Expanded Agreement With ACON Laboratories, Inc.

Innovus Pharma Enters The $11 Billion Glucose Monitoring Market With FDA-Cleared Products Via An Expanded Agreement With ACON Laboratories, Inc.

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and...

Innovus Pharma Announces Agreement With ACON Laboratories, Inc.

Innovus Pharma Announces Agreement With ACON Laboratories, Inc.

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and...

Innovus Pharmaceuticals To Release Third Quarter 2017 Financial Results And Provide Corporate Update On Tuesday, November 14, 2017

Innovus Pharmaceuticals To Release Third Quarter 2017 Financial Results And Provide Corporate Update On Tuesday, November 14, 2017

Innovus Pharmaceuticals, Inc., ("Innovus Pharma") (OTCQB: INNV), today announced that the Company will release its third quarter 2017 financial results and provide a corporate update on Tuesday, November 14, 2017, after the...

Innovus Pharma To Exhibit At 2017 American Society Of Reproductive Medicine ("ASRM") Scientific Congress And Expo In San Antonio, Texas

Innovus Pharma To Exhibit At 2017 American Society Of Reproductive Medicine ("ASRM") Scientific Congress And Expo In San Antonio, Texas

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and...

Innovus Pharma Receives Approval From Health Canada For Vesele As A Natural Health Product

Innovus Pharma Receives Approval From Health Canada For Vesele As A Natural Health Product

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and...

Innovus Pharmaceuticals Expands Its International Proprietary Product Patent Portfolio With Its First Chinese Patent

Innovus Pharmaceuticals Expands Its International Proprietary Product Patent Portfolio With Its First Chinese Patent

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization,...

Innovus Pharma Announces The Availability Of The Full Label For Its Nasal Drug FlutiCare™ For Allergy Symptom Relief On DailyMed

Innovus Pharma Announces The Availability Of The Full Label For Its Nasal Drug FlutiCare™ For Allergy Symptom Relief On DailyMed

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization,...

Innovus Pharma's Partner Luminarie Receives Approval For Zestra® For Female Sexual Arousal Disorder As A Medical Device I From New Zealand's Medicines And Medical Devices Safety Authority

Innovus Pharma's Partner Luminarie Receives Approval For Zestra® For Female Sexual Arousal Disorder As A Medical Device I From New Zealand's Medicines And Medical Devices Safety Authority

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization,...

Innovus Pharma Announces The Launch Of Zestra® In France, Belgium And Monaco By Its Partner, Densmore

Innovus Pharma Announces The Launch Of Zestra® In France, Belgium And Monaco By Its Partner, Densmore

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization,...

Innovus Pharma Receives Approval From Health Canada For Its UriVarx™ Product For The Indication To Reduce Symptoms Of Overactive Bladder Such As Daytime Urinary Frequency, Urgency And Nocturia

Innovus Pharma Receives Approval From Health Canada For Its UriVarx™ Product For The Indication To Reduce Symptoms Of Overactive Bladder Such As Daytime Urinary Frequency, Urgency And Nocturia

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and...

Innovus Pharma To Present At Rodman & Renshaw 19th Annual Global Investment Conference

Innovus Pharma To Present At Rodman & Renshaw 19th Annual Global Investment Conference

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and...

Innovus Pharma Files Product License Application For The Commercialization Of Its Seasonal Allergic Rhinitis Product In Canada

Innovus Pharma Files Product License Application For The Commercialization Of Its Seasonal Allergic Rhinitis Product In Canada

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company, today announced the filing of a Natural Health Product License Application...

Innovus Pharmaceuticals Reports A Quarterly Net Revenue Increase Of 99.2% And Net Loss Decrease Of 74.1% Compared To The Same Period In 2016

Innovus Pharmaceuticals Reports A Quarterly Net Revenue Increase Of 99.2% And Net Loss Decrease Of 74.1% Compared To The Same Period In 2016

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB: INNV) today announced second quarter 2017 net revenue of $2.